Form 8-K

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): March 9, 2004

 

AMEDISYS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

(State or Other Jurisdiction of

Incorporation or Organization)

 

0-24260   11-3131700
(Commission File Number)   (I.R.S. Employer Identification No.)

 

11100 Mead Road, Suite 300, Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

 

(225) 292-2031

(Registrant’s telephone number, including area code)

 

ITEM 7.    FINANCIAL STATEMENTS AND EXHIBITS

 

(a)    Financial Statements of Business Acquired.

 

Not applicable.

 

(b)    Pro Forma Financial Information.

 

Not applicable.

 

(c)    Exhibit No.

 

32.1 (i)    Certification of William F. Borne, Chief Executive Officer

 

32.2 (i)    Certification of Gregory H. Browne, Chief Financial Officer

 

99.1 (i)    Press Release dated March 9, 2004 announcing the Company’s fourth quarter and year end 2003

operating results

 

(i) Filed herewith.

 

ITEM 9.    REGULATION FD DISCLOSURE

 

On March 9, 2004, Amedisys, Inc., “the Company”, issued a press release attached hereto as Exhibit 99.1 releasing fourth quarter and year end 2003 operating results.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMEDISYS, INC.

By:   /s/    Gregory H. Browne
   

Gregory H. Browne

Chief Financial Officer

 

DATE: March 9, 2004